28 min ago | Applied Clinical Trials
Takeda And Lundbeck Present Results From Pivotal Phase 3 Clinical...
These data will be presented at the 2013 American Psychiatric Association Annual Meeting in The objective of these four studies was to evaluate the efficacy and safety profile of vortioxetine in doses ranging from 10-20 mg per day, complementing other studies in the New Drug Application submission package that included dose ranges of 5-20 mg per ... (more)
Raw Milk Regulations and Transparency: Who Needs Them, and Why?PART 4 ...
In the past few weeks, you may have asked yourselves,"Why should I care about Raw Milk regulations? I don't drink raw milk." Does this concern Illinois citizens? In February, Gov.
Will ASCO Unlock Big Value in This Cancer Drug Class?
The single, easiest way to keep track of all the stocks that matter... Your own personalized stock watchlist! It's a 100% FREE Motley Fool service... ) cancer wonder drug Avastin has been a godsend to cancer patients and investors alike.
ServSafe Food Safety course to be offered
The West Virginia University Randolph County Extension Service will host a ServSafe certification course and exam on May 29 and 30.
'Got aspartame in your kids' milk?' FDA urged to reject flavoured milk sweetener petition
US consumer group SumOfUs has plastered its new " Got Aspartame in your kids' milk?" poster on buses destined for Food and Drug Administration HQ, in a last-ditch attempt to convince the authority not to approve a proposed amendment to the standard identity for milk.
NYC Fish Processors Face Contamination Suit, FDA Seeks Preliminary Injunction
The U.S. Department of Justice demanded an injunction Friday on behalf of the U.S. Food and Drug Administration against New York City Fish, Inc.
FDA has pedal to the metal on regulations
Tom Stenzel, president and chief executive officer of the Washington, D.C.-based United Fresh Produce Association, made an interesting analogy along those lines at a May 16 workshop of wholesalers and distributors during United Fresh's show.
Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S.
Oramed Pharmaceuticals Inc. , a developer of oral drug delivery systems, announced today that the United States Food and Drug Administration has cleared the Company's Investigational New Drug application for ORMD-0801, its oral insulin capsule.
3 Most Important Upcoming FDA Decisions of 2013
Keep track of the stocks that matter to you. Help yourself with the Fool's FREE and easy new watchlist service today.
West Jordan man pleads guilty to falsely advertising, selling Viagra-like drug
A West Jordan man charged with selling a Viagra-like drug as a natural supplement has pleaded guilty to charges in two separate federal indictments.
FDA approves Roche diagnostic for gene mutation in lung cancer
A logo of Swiss pharmaceutical company Roche is pictured at a company's building in Rotkreuz, April 12, 2012.
Former FDA official on GMO labeling: 'Science doesn't always win'
Whether the food industry likes it or not, when it comes to GMO labeling, the " train appears to have left the station", according to former FDA associate commissioner of foods Dr David Acheson.
Look for new, improved sunscreen labels
FRIDAY, May 10 -- New labeling laws for sunscreen will help American consumers choose the product that provides the best sun protection, experts say.
Teva treads lightly in morning-after controversy
The recent controversy surrounding the morning-after contraceptive pill called Plan B One-Step has been argued in political, regulatory, and legal circles.
There's a running joke about how bad the food served on planes can be, but taste might not be the biggest concern.
Generic Drug Maker Pleads Guilty, Agrees to Pay $500 Million in Fines
Ranbaxy, an India-based generic drug manufacturer, has pleaded guilty to federal drug safety violations and has agreed to pay $500 million in fines to resolve claims that it sold substandard drugs, The New York Times reports.
Janssen Biotech drug gets FDA nod
The Food and Drug Administration approved the use of Janssen Biotech's Simponi for the treatment of moderately-to-severely active ulcerative colitis in adult patients who have demonstrated corticosteroid dependence or did not respond to other therapies.
New drug may help immune system fight cancer
An experimental drug that taps the power of the body's immune system to fight cancer is shrinking tumors in patients for whom other treatments have failed, an early study shows.
Clostridium botulinum fears prompt FDA action
A fear that carrot and beet juice from a US company could be contaminated with Clostridium botulinum has prompted the US Food and Drug Administration to warn consumers about the potential health risks.
FDA approves J&J's Simponi to treat ulcerative colitis
The Food and Drug Administration has approved Johnson & Johnson's drug Simponi for patients with moderate to severe ulcerative colitis, an inflammatory disease affecting the colon.